Target intelligence / Profile preview

Mitochondrially encoded transfer RNA alanine (MT-TA)

Target
MT-TA
Molecular classification
Other (mitochondrial tRNA)
01

Overview

Mitochondrially encoded transfer RNA alanine (MT-TA) is a short non-coding RNA, 69 nucleotides in length, encoded by the mitochondrial genome in humans[2][3]. Its primary function is to transport the amino acid alanine to mitochondrial ribosomes during mitochondrial translation, facilitating the synthesis of proteins essential for the oxidative phosphorylation (OXPHOS) system[1][2]. MT-TA operates as an adapter molecule, decoding mRNA codons into amino acids via its anticodon and is aminoacylated by a specific mitochondrial aminoacyl-tRNA synthetase[4][6]. Mutations in MT-TA have been implicated in various mitochondrial diseases, including myotonic dystrophy-like myopathy, by disrupting mitochondrial protein synthesis and, consequently, cellular energy production[1][2][7]. These mutations can manifest in tissues with high energy requirements, leading to diverse clinical presentations ranging from muscular dystrophy to generalized mitochondrial disorders[1][2].

Other names
trnAmt-tRNA-Alamitochondrially encoded tRNA-AlatRNA(Ala)tRNA-AlatRNA alanine
02

Biological functions

Protein synthesisMitochondrial translationAmino acid transport (alanine)Adapter in translation
03

Disease associations

Neuromuscular diseaseMyopathyMitochondrial diseaseMyotonic dystrophy-like myopathy
04

Safety considerations

Mutations may lead to mitochondrial dysfunction, impaired energy metabolism, and neuromuscular symptoms[1][2]
05

Biomarkers

Mutations in MT-TA can act as biomarkers for mitochondrial myopathies and related mitochondrial disorders[1][2][7]

Beyond the preview

Go deeper on Mitochondrially encoded transfer RNA alanine (MT-TA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrially encoded transfer RNA alanine (MT-TA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call